A new artificial intelligence (AI) tool has been developed to optimize the design of antibody drugs, a type of medicine used to treat a variety of illnesses. This tool has the potential to improve the efficacy of antibody drugs and speed up the process of drug discovery. The AI tool was developed by a team of researchers from the University of Cambridge and the University of Edinburgh, and utilizes a novel approach to drug design. By combining techniques from machine learning and molecular modelling, the researchers were able to create an AI system that could accurately predict how a particular antibody drug would interact with its target. This information can be used to optimize the design of the drug, making it more effective at treating illnesses.

Read Full Article Here

source: Phys.org